Thymidine kinase: the future in breast cancer prognosis
- 30 June 1995
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 4 (2) , 79-83
- https://doi.org/10.1016/0960-9776(95)90000-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancerBritish Journal of Cancer, 1992
- Prognostic factors in breast cancerBritish Journal of Cancer, 1992
- The future of prognostic factors in outcome prediction for patients with cancerCancer, 1992
- Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast CancerNew England Journal of Medicine, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989
- THE PREVENTION OF BREAST CANCERThe Lancet, 1986
- Expression of thymidine kinase variants is a function of the replicative state of cellsCell, 1974
- Acquisition of thymidine kinase activity by herpes simplex infected mouse fibroblast cellsBiochemical and Biophysical Research Communications, 1963